Allianz Asset Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,620	Closed	-$372K	–	2231
2023 Q1	$372K	Buy	3,620 +1,216	+51%	+$171K	﹤0.01%	1953
2022 Q4	$352K	Hold	2,404	–	–	﹤0.01%	1791
2022 Q3	$406K	Sell	2,404 -7,005	-74%	-$1.14M	﹤0.01%	1558
2022 Q2	$1.09M	Buy	9,409 +1,068	+13%	+$100K	﹤0.01%	1647
2022 Q1	$832K	Sell	8,341 -2,634	-24%	-$308K	﹤0.01%	1941
2021 Q4	$1.71M	Buy	10,975 +1,677	+18%	+$326K	﹤0.01%	1667
2021 Q3	$2.19M	Sell	9,298 -2,040	-18%	-$596K	﹤0.01%	1628
2021 Q2	$3.85M	Buy	11,338 +59	+0.5%	+$22.3K	﹤0.01%	1228
2021 Q1	$4.56M	Buy	11,279 +2,122	+23%	+$1.03M	﹤0.01%	1111
2020 Q4	$6.09M	Sell	9,157 -293	-3%	-$163K	0.01%	984
2020 Q3	$4.4M	Buy	9,450 +3,801	+67%	+$1.92M	0.01%	1026
2020 Q2	$3.3M	Buy	+5,649	New	+$1.93M	﹤0.01%	1381
2019 Q3	–	Sell	-2,090	Closed	-$212K	–	2775
2019 Q2	$212K	Buy	2,090 +43	+2%	+$5.07K	﹤0.01%	2594
2019 Q1	$269K	Buy	2,047 +1,181	+136%	+$149K	﹤0.01%	2510
2018 Q4	$88K	Sell	866 -959	-53%	-$152K	﹤0.01%	2563
2018 Q3	$456K	Sell	1,825 -800	-30%	-$268K	﹤0.01%	2398
2018 Q2	$1.17M	Hold	2,625	–	–	﹤0.01%	2171
2018 Q1	$1.03M	Sell	2,625 -659	-20%	-$260K	﹤0.01%	2198
2017 Q4	$1.35M	Hold	3,284	–	–	﹤0.01%	2144
2017 Q3	$1.42M	Buy	+3,284	New	+$1.29M	﹤0.01%	2125